By contrast, when engineered NPCs, in which the NFκB pathway has been inhibited, are implanted in HFD-fed obese mice, the survival rates of these NPCs dramatically increase, reducing the phenotypic effects of HFD, including increased food intake, weight gain, glucose intolerance and hyperinsulinemia [393]. Here, NFKB1 is linked to Hyperinsulinemia.